|
Onglyza® (saxagliptin) achieves primary safety endpoint in SAVOR cardiovascular outcomes trial
|
02 September 2013 |
|
Bristol-Myers Squibb and Samsung BioLogics announce biopharmaceutical manufacturing relationship
|
29 July 2013 |
|
Bristol-Myers Squibb reports second quarter 2013 financial results
|
25 July 2013 |
|
Bristol-Myers Squibb and Simcere enter partnership to co-develop and co-commercialize Orencia® SC (abatacept) in China
|
14 June 2013 |
|
FDA grants Priority Review to Bristol-Myers Squibb and AstraZeneca's Metreleptin
|
04 June 2013 |
|
Bristol-Myers Squibb and Pfizer announce publication of ARISTOTLE subanalysis in Circulation
|
06 May 2013 |
|
Bristol-Myers Squibb reports first quarter 2013 financial results
|
25 April 2013 |
|
Bristol-Myers Squibb enters a collaboration agreement with Reckitt Benckiser Group plc
|
12 February 2013 |
|
Bristol-Myers Squibb reports fourth quarter financial results
|
24 January 2013 |
|
FDA approves ELIQUIS® (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
|
02 January 2013 |
|
Bristol-Myers Squibb Foundation's Together on Diabetes™ marks World Diabetes Day
|
14 November 2012 |
|
Portola, Bristol-Myers Squibb and Pfizer sign clinical collaboration agreement to study ELIQUIS® and Portola's universal Factor Xa inhibitor antidote PRT4445
|
01 November 2012 |
|
Bristol-Myers Squibb reports third quarter 2012 financial results
|
24 October 2012 |
|
YERVOY® (ipilimumab) awarded prestigious Prix Galien USA 2012 for best biotechnology product
|
17 October 2012 |
|
ELIQUIS® (apixaban) demonstrates consistent reductions in stroke and systemic embolism, major bleeding and mortality
|
02 October 2012 |
|
Vanderbilt University and Bristol-Myers Squibb sign collaboration agreement to develop novel treatments for parkinson's Disease
|
23 September 2012 |
|
Bristol-Myers Squibb and AstraZeneca complete expansion of diabetes alliance
|
09 August 2012 |
|
Bristol-Myers Squibb Foundation awards $1.6 million in grants
|
06 August 2012 |
|
Bristol-Myers Squibb and AstraZeneca expand diabetes alliance
|
01 July 2012 |
|
Bristol-Myers Squibb and Emory University announce partnership
|
20 June 2012 |